Insulet (PODD) Cash from Operations (2010 - 2026)
Insulet (PODD) posted Cash from Operations of 113800000.0 for Q1 2026, down 37.92% on a QoQ basis from 183300000.0 in Q4 2025, and up 78.37% year-over-year from 63800000.0 in Q1 2025.
Insulet (PODD) Cash from Operations (2010 - 2026) Analysis & Trends
Insulet's Cash from Operations history runs 17 years deep, the most recent figure standing at 113800000.0 for Q1 2026.
- Quarterly Cash from Operations rose 78.37% year-over-year to 113800000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 619300000.0 (up 52.39% YoY) and the FY2025 annual result came in at 569300000.0, up 32.33% from the prior year.
- Cash from Operations was 113800000.0 for Q1 2026 at Insulet, down from 183300000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 196500000.0 in Q2 2025 and bottomed at 13700000.0 in Q1 2022.
- A 5-year average of 81058823.53 and a median of 63800000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations soared 17420.0% — and 2025, when it retreated 27.17%.
- Insulet's Cash from Operations stood at 50700000.0 in 2022, then fell by 10.85% to 45200000.0 in 2023, then surged by 226.33% to 147500000.0 in 2024, then climbed by 24.27% to 183300000.0 in 2025, then plunged by 37.92% to 113800000.0 in 2026.
- Business Quant data shows PODD's Cash from Operations at 113800000.0 in Q1 2026, 183300000.0 in Q4 2025, and 125700000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 525.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 290.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 220.10 Mn |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | 113.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 113.80 Mn |
| Mar 31, 2026 | 113.80 Mn |
| Dec 31, 2025 | 183.30 Mn |
| Dec 31, 2025 | 183.30 Mn |
| Sep 30, 2025 | 125.70 Mn |
| Sep 30, 2025 | 125.70 Mn |
| Jun 30, 2025 | 196.50 Mn |
| Jun 30, 2025 | 196.50 Mn |
| Mar 31, 2025 | 63.80 Mn |
| Mar 31, 2025 | 63.80 Mn |
| Dec 31, 2024 | 147.50 Mn |
| Dec 31, 2024 | 147.50 Mn |
| Sep 30, 2024 | 108.30 Mn |
| Sep 30, 2024 | 108.30 Mn |
| Jun 30, 2024 | 86.80 Mn |
| Jun 30, 2024 | 86.80 Mn |
| Mar 31, 2024 | 87.60 Mn |
| Mar 31, 2024 | 87.60 Mn |
| Dec 31, 2023 | 45.20 Mn |
| Dec 31, 2023 | 45.20 Mn |